Regeneron’s Pasatru wins FDA approval in ultra-rare ‘stone man disease’ Pharmaceutical Technology 4d Pharmaceutical Technology 4d FDA Biotech Pharma All sources
Meet Audrey Zheng, the 17-year-old Pennsylvania student who developed a pancreatic cancer test; it correctly identified 87% of patients and 87.5% without the disease The Times of India 4d The Times of India 4d Pennsylvania Schools Biotech Pharma
STAT Plus: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more STAT 4d STAT 4d Biology Biotech Pharma
Sam Chun Dang clears Eylea patent disputes as SCD411 exports grow Korea Biomedical Review 5d Korea Biomedical Review 5d Patent Law Intellectual Property Pharma
BIOCON launches aflibercept biosimilar in the United States JD Supra 3d JD Supra 3d YESAFILI Biotech Pharma
Minnesota teen Evan Morris built a low-cost system that detected seizure-like activity in worms and triggered ultrasound; recurrence fell 70.1% in his model The Times of India 08:47 Sat, 15 Aug The Times of India 08:47 Sat, 15 Aug Biotech Pharma
Does First-in-Class FOP Drug Approval Transform the Bull Case For Regeneron Pharmaceuticals (REGN)? Simply Wall St 12:41 Sun, 23 Aug
Action Alleging Drug Company Kickback Scheme Is Revived Metropolitan News-Enterprise, Los Angeles 15:14 Fri, 21 Aug
Regn Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regeneron Pharmaceuticals Securities Lawsuit - Contact Levi & Korsinsky Business Wire (Press Release) 15:19 Thu, 20 Aug
STAT Plus: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more STAT 14:12 Thu, 20 Aug
Regeneron’s Pasatru wins FDA approval in ultra-rare ‘stone man disease’ Pharmaceutical Technology 12:11 Thu, 20 Aug
Pasatru’s FDA Approval Puts Regeneron’s Rare-Disease Playbook To The Test Scrip Pharma Intelligence 23:15 Wed, 19 Aug
Pasatru’s FDA Approval Puts Regeneron’s Rare-Disease Playbook To The Test Scrip Pharma Intelligence 4d
Regeneron’s uveitis setback adds to string of recent pipeline challenges Scrip Pharma Intelligence 5d